{"id":"https://openalex.org/W2068449302","doi":"https://doi.org/10.1038/sj.bjp.0705681","title":"Antianxiety and antidepressant\u2010like effects of AC\u20105216, a novel mitochondrial benzodiazepine receptor ligand","display_name":"Antianxiety and antidepressant\u2010like effects of AC\u20105216, a novel mitochondrial benzodiazepine receptor ligand","alternate_titles":[],"publication_year":2004,"publication_date":"2004-07-29","ids":{"openalex":"https://openalex.org/W2068449302","doi":"https://doi.org/10.1038/sj.bjp.0705681","mag":"2068449302","pmid":"https://pubmed.ncbi.nlm.nih.gov/15249420","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1575165"},"language":"en","primary_location":{"id":"doi:10.1038/sj.bjp.0705681","doi":"https://doi.org/10.1038/sj.bjp.0705681","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0705681","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0705681","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2068449302"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0705681","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103506134","display_name":"Atsuko Kita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I31591830","display_name":"Sumitomo Dainippon Pharma (Japan)","ror":"https://ror.org/04sapgw72","country_code":"JP","type":"company","lineage":["https://openalex.org/I31591830"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Atsuko Kita","raw_affiliation_strings":["Pharmacology & Microbiology Research Laboratories, Dainippon Pharmaceutical Co., Ltd, 33-94 Enoki, Suita 564-0053, Osaka, Japan. atsuko-kita@dainippon-pharm.co.jp","Pharmacology & Microbiology Research Laboratories, Dainippon Pharmaceutical Co., Ltd, 33-94 Enoki, Suita 564-0053, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology & Microbiology Research Laboratories, Dainippon Pharmaceutical Co., Ltd, 33-94 Enoki, Suita 564-0053, Osaka, Japan. atsuko-kita@dainippon-pharm.co.jp","institution_ids":["https://openalex.org/I31591830"]},{"raw_affiliation_string":"Pharmacology & Microbiology Research Laboratories, Dainippon Pharmaceutical Co., Ltd, 33-94 Enoki, Suita 564-0053, Osaka, Japan","institution_ids":["https://openalex.org/I31591830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008740987","display_name":"Hitoshi Kohayakawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I31591830","display_name":"Sumitomo Dainippon Pharma (Japan)","ror":"https://ror.org/04sapgw72","country_code":"JP","type":"company","lineage":["https://openalex.org/I31591830"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hitoshi Kohayakawa","raw_affiliation_strings":["Pharmacology & Microbiology Research Laboratories, Dainippon Pharmaceutical Co., Ltd, 33-94 Enoki, Suita 564-0053, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology & Microbiology Research Laboratories, Dainippon Pharmaceutical Co., Ltd, 33-94 Enoki, Suita 564-0053, Osaka, Japan","institution_ids":["https://openalex.org/I31591830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113975122","display_name":"Tomoko Kinoshita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I31591830","display_name":"Sumitomo Dainippon Pharma (Japan)","ror":"https://ror.org/04sapgw72","country_code":"JP","type":"company","lineage":["https://openalex.org/I31591830"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomoko Kinoshita","raw_affiliation_strings":["Pharmacology & Microbiology Research Laboratories, Dainippon Pharmaceutical Co., Ltd, 33-94 Enoki, Suita 564-0053, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology & Microbiology Research Laboratories, Dainippon Pharmaceutical Co., Ltd, 33-94 Enoki, Suita 564-0053, Osaka, Japan","institution_ids":["https://openalex.org/I31591830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110721697","display_name":"Yoshiaki Ochi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I31591830","display_name":"Sumitomo Dainippon Pharma (Japan)","ror":"https://ror.org/04sapgw72","country_code":"JP","type":"company","lineage":["https://openalex.org/I31591830"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshiaki Ochi","raw_affiliation_strings":["Pharmacology & Microbiology Research Laboratories, Dainippon Pharmaceutical Co., Ltd, 33-94 Enoki, Suita 564-0053, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology & Microbiology Research Laboratories, Dainippon Pharmaceutical Co., Ltd, 33-94 Enoki, Suita 564-0053, Osaka, Japan","institution_ids":["https://openalex.org/I31591830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105837088","display_name":"Keiko Nakamichi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I31591830","display_name":"Sumitomo Dainippon Pharma (Japan)","ror":"https://ror.org/04sapgw72","country_code":"JP","type":"company","lineage":["https://openalex.org/I31591830"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Keiko Nakamichi","raw_affiliation_strings":["Pharmacology & Microbiology Research Laboratories, Dainippon Pharmaceutical Co., Ltd, 33-94 Enoki, Suita 564-0053, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology & Microbiology Research Laboratories, Dainippon Pharmaceutical Co., Ltd, 33-94 Enoki, Suita 564-0053, Osaka, Japan","institution_ids":["https://openalex.org/I31591830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066866446","display_name":"Satoshi Kurumiya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I31591830","display_name":"Sumitomo Dainippon Pharma (Japan)","ror":"https://ror.org/04sapgw72","country_code":"JP","type":"company","lineage":["https://openalex.org/I31591830"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Satoshi Kurumiya","raw_affiliation_strings":["Pharmacology & Microbiology Research Laboratories, Dainippon Pharmaceutical Co., Ltd, 33-94 Enoki, Suita 564-0053, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology & Microbiology Research Laboratories, Dainippon Pharmaceutical Co., Ltd, 33-94 Enoki, Suita 564-0053, Osaka, Japan","institution_ids":["https://openalex.org/I31591830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062929308","display_name":"Kiyoshi Furukawa","orcid":"https://orcid.org/0000-0001-5505-1030","observed_orcids":["https://orcid.org/0000-0001-5505-1030"]},"institutions":[{"id":"https://openalex.org/I31591830","display_name":"Sumitomo Dainippon Pharma (Japan)","ror":"https://ror.org/04sapgw72","country_code":"JP","type":"company","lineage":["https://openalex.org/I31591830"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kiyoshi Furukawa","raw_affiliation_strings":["Pharmacology & Microbiology Research Laboratories, Dainippon Pharmaceutical Co., Ltd, 33-94 Enoki, Suita 564-0053, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology & Microbiology Research Laboratories, Dainippon Pharmaceutical Co., Ltd, 33-94 Enoki, Suita 564-0053, Osaka, Japan","institution_ids":["https://openalex.org/I31591830"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081205120","display_name":"Makoto Oka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I31591830","display_name":"Sumitomo Dainippon Pharma (Japan)","ror":"https://ror.org/04sapgw72","country_code":"JP","type":"company","lineage":["https://openalex.org/I31591830"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Makoto Oka","raw_affiliation_strings":["Research Management, Drug Research Division, Dainippon Pharmaceutical Co., Ltd, 33-94 Enoki, Suita 564-0053, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Management, Drug Research Division, Dainippon Pharmaceutical Co., Ltd, 33-94 Enoki, Suita 564-0053, Osaka, Japan","institution_ids":["https://openalex.org/I31591830"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5103506134"],"corresponding_institution_ids":["https://openalex.org/I31591830"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":1.354,"has_fulltext":true,"cited_by_count":139,"citation_normalized_percentile":{"value":0.76574912,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"142","issue":"7","first_page":"1059","last_page":"1072"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.40939998626708984,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.40939998626708984,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.361299991607666,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.10320000350475311,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/translocator-protein-tspo","display_name":"translocator protein (TSPO)","score":0.9890000224113464},{"id":"https://openalex.org/keywords/anxiolytic-effects","display_name":"anxiolytic effects","score":0.8920000195503235},{"id":"https://openalex.org/keywords/antidepressant-like-effects","display_name":"antidepressant-like effects","score":0.9909999966621399},{"id":"https://openalex.org/keywords/pk11195","display_name":"PK11195","score":0.8920000195503235},{"id":"https://openalex.org/keywords/vogel-conflict-test","display_name":"Vogel conflict test","score":0.9210000038146973},{"id":"https://openalex.org/keywords/forced-swim-test","display_name":"forced swim test","score":0.8920000195503235},{"id":"https://openalex.org/keywords/myorelaxant-effect","display_name":"myorelaxant effect","score":0.699999988079071},{"id":"https://openalex.org/keywords/ethanol-induced-sleep","display_name":"ethanol-induced sleep","score":0.8180000185966492},{"id":"https://openalex.org/keywords/stress-related-disorders","display_name":"stress-related disorders","score":0.8410000205039978},{"id":"https://openalex.org/keywords/anxiety","display_name":"anxiety","score":0.47999998927116394},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.7490000128746033},{"id":"https://openalex.org/keywords/benzodiazepine-receptor-ligands","display_name":"benzodiazepine receptor ligands","score":0.621999979019165}],"concepts":[{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6012186408042908},{"id":"https://openalex.org/C2776175493","wikidata":"https://www.wikidata.org/wiki/Q210402","display_name":"Diazepam","level":2,"score":0.597744345664978},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5835299491882324},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.5667726993560791},{"id":"https://openalex.org/C136569192","wikidata":"https://www.wikidata.org/wiki/Q4880745","display_name":"Behavioural despair test","level":4,"score":0.5033935904502869},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4801894426345825},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.47213345766067505},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.4706030786037445},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.4399050176143646},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.43550363183021545},{"id":"https://openalex.org/C173586616","wikidata":"https://www.wikidata.org/wiki/Q5359685","display_name":"Elevated plus maze","level":3,"score":0.4191008508205414},{"id":"https://openalex.org/C2909738485","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anti-Anxiety Agents","level":3,"score":0.4120880961418152},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.3498725891113281},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.33927690982818604},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3180541396141052},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.27487820386886597},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2703157961368561},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15927153825759888},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.15163764357566833}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000648","qualifier_name":"ultrastructure","is_major_topic":false},{"descriptor_ui":"D003891","descriptor_name":"Desipramine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003975","descriptor_name":"Diazepam","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004569","descriptor_name":"Electroencephalography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008928","descriptor_name":"Mitochondria","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011687","descriptor_name":"Purines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011869","descriptor_name":"Radioligand Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054833","descriptor_name":"Isoindoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058825","descriptor_name":"Serotonin 5-HT1 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1038/sj.bjp.0705681","doi":"https://doi.org/10.1038/sj.bjp.0705681","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0705681","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0705681","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:15249420","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15249420","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Comparative Study"},{"id":"pmh:oai:pubmedcentral.nih.gov:1575165","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1575165/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1038/sj.bjp.0705681","doi":"https://doi.org/10.1038/sj.bjp.0705681","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0705681","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0705681","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2068449302.pdf","grobid_xml":"https://content.openalex.org/works/W2068449302.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W162023759","https://openalex.org/W173938221","https://openalex.org/W1525161181","https://openalex.org/W1596638623","https://openalex.org/W1604272930","https://openalex.org/W1923787816","https://openalex.org/W1947273128","https://openalex.org/W1960932156","https://openalex.org/W1965133186","https://openalex.org/W1966627384","https://openalex.org/W1969187621","https://openalex.org/W1969814314","https://openalex.org/W1970663529","https://openalex.org/W1972982649","https://openalex.org/W1973386992","https://openalex.org/W1979007089","https://openalex.org/W1983684735","https://openalex.org/W1992144144","https://openalex.org/W2011430874","https://openalex.org/W2012568585","https://openalex.org/W2012767314","https://openalex.org/W2013725312","https://openalex.org/W2037484381","https://openalex.org/W2038378894","https://openalex.org/W2039759850","https://openalex.org/W2041852339","https://openalex.org/W2059354993","https://openalex.org/W2060630994","https://openalex.org/W2063724743","https://openalex.org/W2067776651","https://openalex.org/W2070971788","https://openalex.org/W2075672970","https://openalex.org/W2077678165","https://openalex.org/W2094095364","https://openalex.org/W2101073029","https://openalex.org/W2114339510","https://openalex.org/W2116251480","https://openalex.org/W2145493299","https://openalex.org/W2155301275","https://openalex.org/W2238506399","https://openalex.org/W3200510216"],"related_works":["https://openalex.org/W2016859986","https://openalex.org/W2319201633","https://openalex.org/W2046447636","https://openalex.org/W2460134272","https://openalex.org/W2058379934","https://openalex.org/W2409780226","https://openalex.org/W2331337476","https://openalex.org/W1993177267","https://openalex.org/W1979594873","https://openalex.org/W1976414671"],"abstract_inverted_index":{"We":[0],"investigated":[1],"the":[2,56,69,77,107,119,137,160,178,200,213],"ability":[3],"of":[4,97,215],"N-benzyl-N-ethyl-2-(7,8-dihydro-7-methyl-8-oxo-2-phenyl-9H-purin-9-yl)acetamide":[5],"(AC-5216),":[6],"a":[7],"novel":[8],"mitochondrial":[9],"benzodiazepine":[10,62],"receptor":[11],"(MBR)":[12],"ligand,":[13],"to":[14],"produce":[15],"anti-anxiety":[16,66,187],"and":[17,44,75,80,89,122,188,220],"antidepressant-like":[18,189],"effects":[19,67,96,190,202],"in":[20,68,73,76,84,111,143,177],"various":[21],"animal":[22],"models.":[23],"AC-5216":[24,64,98,113,129,168,185,209],"showed":[25],"high":[26,149],"affinity":[27,54],"for":[28,55,212],"MBRs":[29],"prepared":[30],"from":[31],"rat":[32,38,179],"whole":[33],"brain":[34],"(Ki":[35],"0.297":[36],"nm),":[37,50],"glioma":[39,46],"cells":[40,47],"(IC50":[41,48],"3.04":[42],"nm)":[43],"human":[45],"2.73":[49],"but":[51,196],"only":[52],"negligible":[53],"other":[57],"main":[58],"receptors":[59],"including":[60,218],"central":[61],"receptors.":[63],"produced":[65,173],"Vogel-type":[70],"conflict":[71],"test":[72,110],"rats,":[74,112],"light/dark":[78],"box":[79],"social":[81],"interaction":[82],"tests":[83],"mice":[85],"at":[86,146,164],"0.1-3,":[87],"0.003-0.01":[88],"0.01-0.3":[90],"mg":[91,115,152,166,170],"kg(-1),":[92,116,153,167,171],"p.o.,":[93],"respectively.":[94],"These":[95,181],"were":[99],"antagonized":[100],"by":[101,127,194],"PK11195,":[102],"an":[103],"MBR":[104],"antagonist.":[105],"In":[106],"forced":[108],"swimming":[109],"(3-30":[114],"p.o.)":[117,172],"reduced":[118],"immobility":[120],"time,":[121],"this":[123],"effect":[124],"was":[125],"blocked":[126],"PK11195.":[128],"had":[130],"no":[131,174],"myorelaxant":[132],"effects,":[133],"did":[134,157],"not":[135,198],"affect":[136],"memory":[138],"or":[139],"prolong":[140,159],"hexobarbitone-induced":[141],"sleep":[142,162],"mice,":[144],"even":[145],"doses":[147],"as":[148,150],"1000":[151,165],"p.o.":[154],"Although":[155],"it":[156],"slightly":[158],"ethanol-induced":[161],"time":[163],"(1-100":[169],"distinct":[175],"change":[176],"electroencephalogram.":[180],"results":[182],"indicate":[183],"that":[184,191],"produces":[186],"are":[192],"mediated":[193],"MBR,":[195],"does":[197],"cause":[199],"side":[201],"normally":[203],"associated":[204],"with":[205],"conventional":[206],"benzodiazepines.":[207],"Hence,":[208],"shows":[210],"potential":[211],"treatment":[214],"stress-related":[216],"disorders":[217],"anxiety":[219],"depression.":[221]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2068449302","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":17},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
